Vazyme(SH:688105) Xin Lang Cai Jing·2025-10-15 02:29Core Points - The stock price of NuoVivian increased by 2.10% on October 15, reaching 22.82 CNY per share, with a total market capitalization of 9.076 billion CNY [1] - The company has seen a year-to-date stock price increase of 3.63%, but has experienced a decline of 1.68% over the last five trading days [1] - NuoVivian's main business involves the research and development of functional proteins and high molecular organic materials, with a revenue composition of 81.86% from biological reagents and 9.99% from diagnostic reagents [1] Financial Performance - As of June 30, NuoVivian had 8,596 shareholders, an increase of 2.37% from the previous period, while the average circulating shares per person decreased by 2.31% to 46,269 shares [2] - For the first half of 2025, NuoVivian reported a revenue of 606 million CNY, a year-on-year decrease of 6.63%, and a net profit attributable to shareholders of 3.1294 million CNY, down 80.63% year-on-year [2] Dividend Information - Since its A-share listing, NuoVivian has distributed a total of 731 million CNY in dividends, with 611 million CNY distributed over the past three years [3]